[ Price : $8.95]
FDA green lights a Genentech randomized, double-blind, placebo-controlled Phase 3 clinical trial in collaboration with the Biomedi...[ Price : $8.95]
Federal Register notice: FDA permanently debars Stephen Kalinoski from providing services in any capacity to a person that has an ...[ Price : $8.95]
Federal Register notice: FDA permanently debars Gerald Tighe from providing services related to an approved or pending drug produc...[ Price : $8.95]
Federal Register notice: FDA permanently debars Brenda Elise Edwards from providing services in any capacity to a person that has ...[ Price : $8.95]
FDA issues two guidance documents to communicate its policy for temporary manufacturing of certain alcohol-based hand sanitizer pr...[ Price : $8.95]
FDA issues a new policy that allows manufacturers of certain FDA-cleared vital sign-measuring devices to expand their use for heal...[ Price : $8.95]
FDA issues a guidance entitled Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemi...[ Price : $8.95]
After gaining some media attention, a new FDA safety update says it is not aware of scientific evidence connecting the use of NSAI...